Stay updated on TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedA new Revision: v3.6.3 entry was added to the study history and the previous Revision: v3.6.2 entry was removed. This reflects a platform update shown in the record history.SummaryDifference0.1%

- Check14 days agoChange DetectedNew revision entry v3.6.2 appears in the study record history, replacing the previous v3.6.0. This indicates a minor backend or documentation update to the page rather than changes to study content or participant data.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating the study is not enrolling new participants. The record's revision history shows the current version as v3.6.0, replacing the previous v3.5.5.SummaryDifference0.3%

- Check35 days agoChange DetectedA new site revision tag v3.5.5 was added to the record history, replacing the prior v3.5.4 entry, indicating a backend/UI update rather than a change to trial information.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, representing a minor administrative update to the study record history. This change does not alter the study data, status, or visible content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page’s interface revision indicator changed from v3.5.2 to v3.5.3, reflecting an update to the site’s display/versioning rather than the trial record itself.SummaryDifference0.1%

Stay in the know with updates to TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.